Ferritin, Light Chain (Node-Negative Breast Tumor Prognostic Marker)

Product Description

Ferritin, Light Chain (Node-Negative Breast Tumor Prognostic Marker) is available at Gentaur for Next Week Delivery.

Product Short Name:  Ferritin, Light Chain

Other Names: [ferritin light chain; Ferritin light chain; ferritin light chain; ferritin light chain]

Product Gene Name: [FTL]

Other Gene Names: [FTL; FTL; LFTD; NBIA3; Ferritin L subunit]

Clonality:

Isotype: IgG1, kappa

Clone: [rFTL/1388]

Host: Mouse

Reactivity: Human

Specifity: Mammalian ferritins consist of 24 subunits made up of 2 types of polypeptide chains, ferritin heavy chain and ferritin light chain. Ferritin heavy chains catalyze the first step in iron storage, the oxidation of Fe (II), whereas ferritin light chains promote the nucleation of ferrihydrite, enabling storage of Fe (III). Light chain ferritin is involved in cataracts by at least two mechanisms, hereditary hyperferritinemia cataract syndrome, in which light chain ferritin is overexpressed, and oxidative stress, an important factor in the development of ageing-related cataracts.

Purity:  Purified Ab with BSA and Azide at 200ug/ml OR Purified Ab WITHOUT BSA and Azide at 1.0mg/ml

Form: 200ug/ml of Ab Purified from Bioreactor Concentrate by Protein A/G. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0mg/ml.

Concentration: 

Storage Stability:  Antibody with azide: store at 2 to 8 degree C.
Antibody without azide: store at -20 to -80 degree C.
Antibody is stable for 24 months. Non-hazardous. No MSDS required.

Tested Application:  Immunohistochemistry (IHC) Paraffin